40
Participants
Start Date
June 23, 2025
Primary Completion Date
October 31, 2025
Study Completion Date
December 22, 2025
Depigmenting Cosmetic Serum (Applied Morning and Evening)
Participants in Group 1 receive a depigmenting cosmetic serum with non-drug actives applied morning and evening, plus a placebo cream without hydroquinone applied in the evening. Group 2 receives a placebo serum (no active depigmenting ingredients) applied morning and evening, and a hydroquinone 4% cream applied in the evening. All participants apply an SPF50+ sunscreen in the morning throughout the 84-day study. The cosmetic serum is the investigational product; hydroquinone serves as the active comparator. Placebo products are visually matched to their respective actives to ensure blinding. The study distinguishes each intervention by active ingredients, timing of application (morning/evening), and role (test vs. reference vs. supportive care). All products are applied topically, and the regimen remains fixed across the study duration.
RECRUITING
Centre International de Développement Pharmaceutique, Port Louis
CIDP Mauritius
UNKNOWN
Laboratoire Dermatologique ACM
INDUSTRY